Transparency and Disclosure reporting requirements relating to interactions between Pharmaceutical Companies and Healthcare Providers (HCPs) and Healthcare Organizations (HCOs) are increasing both in US and globally.

It is essential that organizations have policies and procedures in place to accurately identify, capture, and report information regarding these interactions, as inaccurate reporting can lead to financial penalties and reputational risk.

We can assist organizations to meet these requirements by:

• Assessment of all HCP /HCO spend sources to identify all available data for aggregation and reporting as required by Federal and State reporting requirements
• Develop assumptions documents of regulations based on organizations legal interpretations
• Advise and assist in the identification and implementation of aggregate spend and reporting systems
• Assist in the development of HCP/HCO spend transparency and reporting policy and procedure documentation
• Provide training on Federal and State reporting requirements
• Audit of HCP/HCO Engagements